Community Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,000
Closed -$416K 58
2023
Q1
$416K Hold
6,000
0.55% 59
2022
Q4
$432K Hold
6,000
0.56% 59
2022
Q3
$427K Sell
6,000
-3,900
-39% -$283K 0.56% 62
2022
Q2
$762K Buy
+9,900
New +$754K 0.93% 41
2021
Q4
Sell
-15,700
Closed -$929K 84
2021
Q3
$929K Hold
15,700
0.96% 40
2021
Q2
$1.05M Buy
15,700
+5,700
+57% +$372K 1.06% 36
2021
Q1
$631K Sell
10,000
-9,000
-47% -$560K 0.7% 52
2020
Q4
$1.18M Buy
19,000
+2,440
+15% +$150K 1.42% 24
2020
Q3
$998K Hold
16,560
1.33% 24
2020
Q2
$974K Hold
16,560
1.07% 28
2020
Q1
$923K Hold
16,560
1.53% 18
2019
Q4
$1.06M Buy
16,560
+8,902
+116% +$510K 1.02% 27
2019
Q3
$388K Buy
+7,658
New +$360K 0.42% 69
2019
Q1
Sell
-4,596
Closed -$239K 161
2018
Q4
$239K Buy
+4,596
New +$247K 0.35% 89

Other funds holding BMY

Community Capital Management's BMY Position: Q2 2023 in Review

Community Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 6,000 shares — an estimated $416K sold.

Community Capital Management first reported a position in BMY in Q4 2018 and held it in 14 quarters. The position peaked at $1.18M in Q4 2020. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Community Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Community Capital Management sold 6,000 Bristol-Myers Squibb shares in Q2 2023, an estimated $416K.
  • Community Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 14 quarters.
  • Community Capital Management's Bristol-Myers Squibb position peaked at $1.18M in Q4 2020.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Community Capital Management's 13F filing for Q2 2023, filed 24 Jul 2023.